Literature DB >> 3834839

Emergence of trimethoprim resistance in fecal flora.

P Huovinen, T Mattila, O Kiminki, L Pulkkinen, S Huovinen, M Koskela, R Sunila, P Toivanen.   

Abstract

The emergence of trimethoprim (TMP) resistance in fecal flora was compared in patients with urinary tract infection treated with TMP or TMP-sulfamethoxazole. No significant differences were found in the occurrence of TMP-resistant fecal aerobic bacteria in the two treatment groups before and after treatment.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3834839      PMCID： PMC180247          DOI： 10.1128/AAC.28.2.354

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

1.  R Factors in Escherichia coli in faeces after oral chemotherapy in general practice.

Authors:  N Datta; M C Faiers; D S Reeves; W Brumfitt; F Orskov; I Orskov
Journal:  Lancet       Date:  1971-02-13       Impact factor: 79.321

2.  Laser nephelometric semi-automated system for rapid bacterial susceptibility testing.

Authors:  R M Guinet; M A Mazoyer
Journal:  J Antimicrob Chemother       Date:  1983-09       Impact factor: 5.790

3.  Trimethoprim R plasmids isolated during long-term treatment of urinary tract infection with co-trimoxazole.

Authors:  K J Towner; N J Pearson; W R Cattell; F O'Grady
Journal:  J Antimicrob Chemother       Date:  1979-01       Impact factor: 5.790

4.  Trimethoprim resistance in Gram negative urinary pathogens.

Authors:  R Maskell
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-12

5.  Effect of trimethoprim on the occurrence of drug-resistant coliform bacteria in the faecal flora.

Authors:  A Toivanen; A Kasan; H Sundquist; P Toivanen
Journal:  Chemotherapy       Date:  1976       Impact factor: 2.544

6.  Effect of trimethoprim and trimethoprim-sulfamethoxazole on development of drug-resistant vaginal and fecal floras.

Authors:  S J Pancoast; D M Hyams; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

7.  Comparison of trimethoprim alone with trimethoprim sulphamethoxazole in the treatment of respiratory and urinary infections with particular reference to selection of trimethoprim resistance.

Authors:  R W Lacey; V L Lord; H K Gunasekera; P J Leiberman; D E Luxton
Journal:  Lancet       Date:  1980-06-14       Impact factor: 79.321

8.  Trimethoprim resistance in hospitals.

Authors:  P Huovinen; R Mäntyjärvi; P Toivanen
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-13

9.  Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.

Authors:  B E Murray; E R Rensimer; H L DuPont
Journal:  N Engl J Med       Date:  1982-01-21       Impact factor: 91.245

10.  Treatment of uncomplicated urinary tract infections with trimethoprim versus sulfisoxazole, with special reference to antibody-coated bacteria and fecal flora.

Authors:  A Iravani; G A Richard; H Baer
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191
View more
  6 in total

Review 1.  Trimethoprim resistance.

Authors:  P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

Review 2.  Trimethoprim and sulfonamide resistance.

Authors:  P Huovinen; L Sundström; G Swedberg; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

3.  Screening for antimicrobial resistance in fecal samples by the replica plating method.

Authors:  M Osterblad; T Leistevuo; P Huovinen
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

4.  Antimicrobial and mercury resistance in aerobic gram-negative bacilli in fecal flora among persons with and without dental amalgam fillings.

Authors:  M Osterblad; J Leistevuo; T Leistevuo; H Järvinen; L Pyy; J Tenovuo; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

5.  A novel dihydrofolate reductase cassette inserted in an integron borne on a Tn21-like element.

Authors:  E Heikkilä; M Skurnik; L Sundström; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

Review 6.  Resistance decay in individuals after antibiotic exposure in primary care: a systematic review and meta-analysis.

Authors:  Mina Bakhit; Tammy Hoffmann; Anna Mae Scott; Elaine Beller; John Rathbone; Chris Del Mar
Journal:  BMC Med       Date:  2018-08-07       Impact factor: 8.775
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.